This federal Project Grant award of $2,065,719, provided by the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research), aims to develop and optimize a community-based behavioral intervention to increase COVID-19 and influenza vaccination rates among African American/Black and Latino (AABL) persons in New York. The study, led by a collaborative team from New York University and the Northern Manhattan Improvement Corporation,...
This Project Grant award from the National Science Foundation (CFDA 47.075 - Social, Behavioral, and Economic Sciences program) provides $375,000 to the National Opinion Research Center (NORC) to conduct a community-engaged study examining the role of social media influencers in addressing vaccine information integrity. The key products and services to be delivered include: Using social listening tools to collect, code, and analyze social media posts and comments about a new respiratory...
This Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) provides $2,058,402 to The Regents of the University of California, San Francisco (UCSF) to adapt and evaluate a community-based intervention to increase respiratory syncytial virus (RSV) vaccine uptake among Latino older adults. The study aims to leverage UCSF's community partnership to adapt two intervention components - community health...
This federal Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) provides $400,000 to the University of California, Irvine to study the influence of social media, social networks, and misinformation on vaccine acceptance among Black and Latinx individuals. The study aims to: 1) identify the relationship between social media data and vaccine acceptance among Black and Latinx followers of...
This Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) provides $1,164,930 to The RAND Corporation to study the impact of school-located vaccination (SLV) models on improving routine, influenza, and COVID-19 vaccination rates among school-aged children in Colorado, particularly for health disparity populations. The key products and services to be delivered include: Describing the SLV models...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) provides $382,852 to Brown University to develop methodological innovations for improving the use of observational causal inference models to estimate the population-level impact of interventions on infectious disease outcomes. The key products and services to be delivered include: Proposing robust specifications for observational...
This $836,895 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund a 5-year research study to develop and evaluate communication strategies to promote HIV vaccine and prevention uptake among young Black women in the Southern U.S. The project, led by researchers at Baylor College of Medicine, will use community-based participatory methods to co-create theory-based messaging, graphics, and videos to...
The National Science Foundation (NSF) awarded a $448,823 Project Grant under its Social, Behavioral, and Economic Sciences program (CFDA 47.075) to the Trustees of Boston University. This two-year grant, running from September 1, 2023 to August 31, 2025, aims to assess the effectiveness of various health communication tactics employed by federal, state, and local agencies to encourage vaccine uptake. The project will build a database of vaccine messaging from public health agencies, evaluate the...
This Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) provides $646,000.00 to West Virginia University Research Corporation to develop novel behavior-informed multi-task machine learning frameworks for targeted public health interventions in rural America. The project leverages insights from the SARS-CoV-2 pandemic, utilizing state-wide testing, vaccination, and hospitalization data from West...
This Project Grant award of $465,000 from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) supports a study to compare technological and relational approaches to engage families who miss scheduled well-child visits. The study aims to: 1) demonstrate feasibility of integrating a new referral protocol for community health worker outreach after missed visits, 2) compare attendance rates after missed visits for...
MOTIVATIONAL INTERVIEWING TRAINING TO PROMOTE COVID-19 AND INFLUENZA VACCINATION (MI-VAX): WHAT PROVIDERS NEED AND PATIENTS WANT - PROJECT SUMMARY/ABSTRACT DECLARED A TOP TEN THREAT TO GLOBAL HEALTH BY THE WORLD HEALTH ORGANIZATION IN 2019, VACCINE HESITANCY CONTINUES TO BE A MAJOR PROBLEM, AS HIGHLIGHTED BY THE ONGOING COVID-19 PANDEMIC. COVID-19 AND INFLUENZA ARE BOTH RESPIRATORY VIRAL ILLNESSES THAT RESULT IN A SUBSTANTIAL NUMBER OF VACCINE-PREVENTABLE ILLNESSES, HOSPITALIZATIONS, AND DEATHS DUE TO SUBOPTIMAL VACCINE UPTAKE IN THE UNITED STATES (US). THERE ARE MAJOR DISPARITIES IN COVID-19 AND INFLUENZA VACCINE UPTAKE ACCORDING TO RACE/ETHNICITY AND SOCIOECONOMIC STATUS. THESE DISPARITIES CONTRIBUTE TO THE DISPROPORTIONATELY HIGH BURDEN OF COVID-19 AND INFLUENZA ILLNESS AMONG THESE VULNERABLE POPULATIONS, WITH HIGHER RATES OF COVID-19 AND INFLUENZA RELATED HOSPITALIZATIONS AND DEATHS AMONG INDIVIDUALS OF RACIAL/ETHNIC MINORITIES, NON-US BORN POPULATIONS, AND LOW SOCIOECONOMIC STATUS. EFFECTIVE STRATEGIES ARE URGENTLY NEEDED TO INCREASE COVID-19 AND INFLUENZA VACCINE UPTAKE AMONG VULNERABLE POPULATIONS. THE OVERALL GOAL OF THIS PROPOSAL IS TO TEST THE IMPACT OF A HIGHLY PROMISING APPROACH, MOTIVATIONAL INTERVIEWING, ON COVID-19 AND INFLUENZA VACCINE HESITANCY AMONG VULNERABLE ADULTS. BUILDING ON EXPERIENCE TRAINING PROVIDERS IN MI AND ONGOING WORK SUPPORTING PCPS IN ADDRESSING COVID-19 VACCINE HESITANCY, WE WILL DEVELOP, IMPLEMENT, AND EVALUATE AN INNOVATIVE MOTIVATIONAL INTERVIEWING TRAINING PROGRAM SPECIFIC TO COVID- 19 AND INFLUENZA VACCINATION FOR PCPS WHO CARE FOR ADULT PATIENTS IN AND NEAR WORCESTER, MA. THE TRAINING PROGRAM WILL INCLUDE: (1) A VIDEO MODULE INTRODUCING PROVIDERS TO KEY PRINCIPLES OF MI AND PRESUMPTIVE RECOMMENDATIONS FOR VACCINATION; (2) OPPORTUNITIES TO PRACTICE MI SKILLS AND RECEIVE FEEDBACK USING AN INNOVATIVE VIDEO-BASED COMMUNICATION ASSESSMENT (VCA) PLATFORM; AND (3) PROVIDER REFERENCE SHEETS WITH SUGGESTED RESPONSES TO COMMON CONCERNS. WE WILL IMPLEMENT AND EVALUATE THE INTERVENTION AT THREE CLINICAL SYSTEMS VIA A LARGE PRAGMATIC CLINICAL TRIAL. THE CLINICAL SYSTEMS INCLUDE UMASS MEMORIAL HEALTH CARE (UMMHC) AND TWO FEDERALLY QUALIFIED HEALTH CENTERS (FQHCS) WHICH COLLECTIVELY SERVE LARGE POPULATIONS OF RACIAL/ETHNIC MINORITY GROUPS, NON-US BORN INDIVIDUALS, AND SOCIOECONOMICALLY DISADVANTAGED PATIENTS. OUR SPECIFIC AIMS ARE: (1) TO DEVELOP A MOTIVATIONAL INTERVIEWING TRAINING PROGRAM FOR PCPS TO ADDRESS COVID-19 AND INFLUENZA VACCINE HESITANCY AMONG ADULT PATIENTS; (2) TO IMPLEMENT AND ASSESS THE IMPACT OF THE MI TRAINING ON COVID-19 AND INFLUENZA VACCINE UPTAKE THROUGH A LARGE, PRAGMATIC CLUSTER RANDOMIZED TRIAL; AND (3) TO EVALUATE THE INTERVENTION ACCORDING TO THE RE-AIM FRAMEWORK, INCORPORATING THE PERSPECTIVES OF PATIENTS AND PRIMARY CARE PROVIDERS. THIS RESEARCH WILL GENERATE URGENTLY NEEDED EVIDENCE FOR TRAINING PCPS TO COMMUNICATE EFFECTIVELY WITH VACCINE HESITANT ADULT PATIENTS. BY DEVELOPING AN EFFICIENT AND SCALABLE PLATFORM FOR TRAINING PCPS IN MI, THIS RESEARCH WILL ALSO CATALYZE THE USE OF MI TO PROMOTE A RANGE OF HEALTH-RELATED BEHAVIOR CHANGES.